BANK OF MONTREAL /CAN/ - OBALON THERAPEUTICS INC ownership

OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 58 filers reported holding OBALON THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of OBALON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$0710.0%0.00%
Q1 2019$0
-100.0%
71
-87.4%
0.00%
Q4 2018$1,000
-50.0%
5620.0%0.00%
Q3 2018$2,000
+100.0%
5620.0%0.00%
Q2 2018$1,000
-75.0%
562
-54.5%
0.00%
Q1 2018$4,0001,235
+1639.4%
0.00%
Q4 2017$0
-100.0%
710.0%0.00%
Q3 2017$1,000710.00%
Other shareholders
OBALON THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 2,453,338$16,217,0005.54%
Tamarack Advisers, LP 604,036$3,993,0002.18%
LEVEL FOUR ADVISORY SERVICES, LLC 330,427$2,184,0000.17%
Moisand Fitzgerald Tamayo, LLC 6,677$288,0000.17%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 446,284$2,950,0000.12%
FORMULA GROWTH LTD 108,998$720,0000.10%
Granite Investment Partners, LLC 108,758$719,0000.04%
TIVERTON ASSET MANAGEMENT LLC 103,036$681,0000.04%
Bellevue Group AG 48,000$317,0000.03%
C WorldWide Group Holding A/S 276,211$1,826,0000.03%
View complete list of OBALON THERAPEUTICS INC shareholders